B Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Sale of Barnes Group to Apollo Global Management
07 oct. 2024 09h23 HE
|
Wohl & Fruchter LLP
We are investigating the fairness of the proposed sale of Barnes Group to Apollo Global Management for $47.50 per share in cash.
SMAR Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Sale of Smartsheet to Vista Equity Partners and Blackstone
24 sept. 2024 11h34 HE
|
Wohl & Fruchter LLP
We are investigating fairness of proposed sale of Smartsheet to Vista Equity and Blackstone for $56.50 per share in cash.
INDV Alert: Monsey Law Firm of Wohl & Fruchter LLP Reminds Indivior Investors of Important Deadline in Class Action Lawsuit
20 sept. 2024 09h52 HE
|
Wohl & Fruchter LLP
Monsey law firm of Wohl & Fruchter LLP reminds Indivior investors of important deadline in pending class action against Indivior.
GATO Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Proposed Merger of Gatos Silver With First Majestic Silver
05 sept. 2024 09h35 HE
|
Wohl & Fruchter LLP
We are investigating the fairness of the proposed merger of Gatos Silver with First Majestic Silver in a deal that values Gatos at $13.49 per share.
FYBR Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Proposed Sale of Frontier Communications to Verizon
05 sept. 2024 09h26 HE
|
Wohl & Fruchter LLP
We are investigating the fairness of the proposed sale of Frontier Communications to Verizon for $38.50 per share in cash.
SILK Alert: Monsey Firm of Wohl & Fruchter Renews Investigation of the Proposed Sale of Silk Road Medical to Boston Scientific
19 août 2024 09h31 HE
|
Wohl & Fruchter LLP
We have renewed our investigation into the fairness of the proposed sale of Silk Road Medical to Boston Scientific for $27.50 per share.
LLAP Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Sale of Terran Orbital to Lockheed Martin
15 août 2024 14h37 HE
|
Wohl & Fruchter LLP
We are investigating the fairness of the proposed sale of Terran Orbital to Lockheed Martin for $0.25 per share in cash.
RVNC Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Sale of Revance Therapeutics to Crown Laboratories
12 août 2024 09h33 HE
|
Wohl & Fruchter LLP
We are investigating the fairness of the proposed sale of Revance Therapeutics to Crown Laboratories for $6.66 per share in cash.
RCM Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Sale of R1 RCM to TowerBrook Capital Partners and Clayton, Dubilier & Rice
01 août 2024 16h56 HE
|
Wohl & Fruchter LLP
We are investigating the fairness of the proposed sale of RCM to TowerBrook and Clayton Dubilier & Rice for $14.30 per share in cash
MORF Alert: Wohl & Fruchter LLP Files Class Action Lawsuit on Behalf of Shareholders of Morphic Holding, Inc., in the U.S. District Court for the Northern District of California
31 juil. 2024 09h15 HE
|
Wohl & Fruchter LLP
We have filed a class action lawsuit on behalf of Morphic shareholders alleging securities claims in connection with the proposed sale to Eli Lilly.